Measurement of IFNα attomolar concentrations by digital ELISA will enhance our understanding of IFN biology and potentially improve the diagnosis and stratification of pathologies associated with IFN dysregulation.
Resources by Therapeutic Area
Journal of Experimental Medicine | April 18, 2017
Evaluation Of Th2 And Th17 Cytokine Levels In Serum From Asthmatics Using The High Sensitivity Quanterix Simoa HD-1 Platform
American Thoracic Society | May 15, 2016
This study investigated the capability of the Quanterix Simoa HD-1 to measure interleukin (IL)-5 , - 13, and -17A in serum samples to determine if increasing assay sensitivity will allow us to convincingly detect these cytokines at baseline.
Development of an ultra-sensitive Simoa assay to enable GDF11 detection: a comparison across bioanalytical platforms
Bioanalysis | February 26, 2016
Four bioanalytical platforms were evaluated to optimize sensitivity and enable detection of recombinant human GDF11 in biological matrices. Simoa achieved the greatest sensitivity, an improvement of 100-fold over the next sensitive platform.
January 25-26, 2016
San Diego, CA USA January 25-26, 2016 Registration at www.gtcbio.com
Immunochemistry for high-throughput screening of human exhaled breath condensate (EBC) media: implementation of automated Quanterix SIMOA instrumentation
Journal of Breath Research| December 11, 2015
Immunochemistry is an important clinical tool for indicating biological pathways leading towards disease. Standard enzyme-linked immunosorbent assays (ELISA) are labor intensive and lack sensitivity at low-level concentrations. Here we report on emerging technology implementing fully automated ELIS…